Edwards Lifesciences

Edwards Lifesciences EW Stock

$90.28   0.545715%
Add to favorites
Exchange
Market Cap
$51.98B
LOW - HIGH [24H]
$89.46 - $90.62
VOLUME [24H]
$696.07K
P/E Ratio
53.73
Earnings per share
$1.68
ISIN
US28176E1082
Price   Prediction

Edwards Lifesciences Price Chart

Sorry, that's all we've gotfor now...

Edwards Lifesciences EW Financial and Trading Overview

Edwards Lifesciences stock price 90.28 USD
Previous Close 89.83 USD
Open 89.89 USD
Bid 89.77 USD x 10000
Ask 89.77 USD x 40000
Day's Range 88.79 - 90.36 USD
52 Week Range 72.3 - 96.29 USD
Volume 2.08M USD
Avg. Volume 4.79M USD
Market Cap 51.75B USD
Beta (5Y Monthly) 0.846
PE Ratio (TTM) 53.44643
EPS (TTM) 1.68 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 100.96 USD

EW Valuation Measures

Enterprise Value 48.34B USD
Trailing P/E 53.44643
Forward P/E 26.584751
PEG Ratio (5 yr expected) 2.22
Price/Sales (ttm) 7.947262
Price/Book (mrq) 4.875916
Enterprise Value/Revenue 7.422
Enterprise Value/EBITDA 24.207

Trading Information

Edwards Lifesciences Stock Price History

Beta (5Y Monthly) 0.846
52-Week Change 9.77%
S&P500 52-Week Change 18.15%
52 Week High 96.29 USD
52 Week Low 72.3 USD
50-Day Moving Average 88.91 USD
200-Day Moving Average 84.62 USD

EW Share Statistics

Avg. Volume (3 month) 4.79M USD
Avg. Daily Volume (10-Days) 2.91M USD
Shares Outstanding 576.4M
Float 574.49M
Short Ratio 1.97
% Held by Insiders 0.19%
% Held by Institutions 97.11%
Shares Short 10.04M
Short % of Float 1.98%
Short % of Shares Outstanding 1.73%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 3:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 15.43%
Operating Margin (ttm) 29.83%
Gross Margin 77.83%
EBITDA Margin 30.66%

Management Effectiveness

Return on Assets (ttm) 8.36%
Return on Equity (ttm) 9.17%

Income Statement

Revenue (ttm) 6.51B USD
Revenue Per Share (ttm) 11.22 USD
Quarterly Revenue Growth (yoy) 13.60%
Gross Profit (ttm) 5.07B USD
EBITDA 2B USD
Net Income Avi to Common (ttm) 979.9M USD
Diluted EPS (ttm) 1.68
Quarterly Earnings Growth (yoy) -27.40%

Balance Sheet

Total Cash (mrq) 4.25B USD
Total Cash Per Share (mrq) 7.38 USD
Total Debt (mrq) 704.4M USD
Total Debt/Equity (mrq) 6.57 USD
Current Ratio (mrq) 4.522
Book Value Per Share (mrq) 18.415

Cash Flow Statement

Operating Cash Flow (ttm) 1.72B USD
Levered Free Cash Flow (ttm) 1.23B USD

Profile of Edwards Lifesciences

Country United States
State CA
City Irvine
Address One Edwards Way
ZIP 92614
Phone 949 250 2500
Website https://www.edwards.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 16000

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Q&A For Edwards Lifesciences Stock

What is a current EW stock price?

Edwards Lifesciences EW stock price today per share is 90.28 USD.

How to purchase Edwards Lifesciences stock?

You can buy EW shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Edwards Lifesciences?

The stock symbol or ticker of Edwards Lifesciences is EW.

Which industry does the Edwards Lifesciences company belong to?

The Edwards Lifesciences industry is Medical Devices.

How many shares does Edwards Lifesciences have in circulation?

The max supply of Edwards Lifesciences shares is 575.8M.

What is Edwards Lifesciences Price to Earnings Ratio (PE Ratio)?

Edwards Lifesciences PE Ratio is 53.73809400 now.

What was Edwards Lifesciences earnings per share over the trailing 12 months (TTM)?

Edwards Lifesciences EPS is 1.68 USD over the trailing 12 months.

Which sector does the Edwards Lifesciences company belong to?

The Edwards Lifesciences sector is Healthcare.

Edwards Lifesciences EW included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us S&P 500 (Yahoo.com) GSPC US 7660.48 USD
-0.18
888.18M USD 7638.17 USD 7665.21 USD 888.18M USD
us S&P 500 INDEX SPX US 7662.2 USD
-0.16
830M USD 7638.17 USD 7663.46 USD 830M USD
us US Tech CRD Global Sustainabilit NQCRD US 1735.62 USD
0
1715.94 USD 1757.95 USD
us NYSE Composite Index NYA US 24687.33 USD
-0.17
24675.17 USD 24749.89 USD
us NQ US Medical Supplies Lg Md C NQUSB4537LMJPYT US 3149.56 JPY 19.42 USD
<0.01
3149.56 JPY 19.42 USD 3149.56 JPY 19.42 USD
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD
us NQ US Medical Supplies Large M NQUSB4537LMN US 3087.37 USD
<0.01
3057.02 USD 3124.33 USD
us US Tech US Price Setters Index NQPRCE US 3159.69 USD
+0.43
3148.58 USD 3166.62 USD
$2.67T
Total marketcap
$113.77B
Total volume
BTC 59.07%     ETH 11.16%
Dominance
Select currency